Quantcast

Latest Parkinson's disease Stories

2014-06-18 12:18:46

Journal of Clinical Investigation Parkinson's disease, which affects millions worldwide, results from neuron loss. Transplantation of fetal tissue to restore this loss has shown promise, but ethical concerns over acquiring this tissue limit its use. In a June 17 study in the Journal of Clinical Investigation, Vania Broccoli and others at the San Raffaele Scientific Institute converted fibroblasts into neurons and engrafted them into the brains of rodents with parkinsonism. The cells...

2014-06-12 13:03:50

University of Oxford Oxford University researchers funded by Parkinson's UK have developed a simple and quick MRI technique that offers promise for early diagnosis of Parkinson's disease. The team demonstrated that their new MRI approach can detect people who have early-stage Parkinson's disease with 85% accuracy, according to research published in Neurology, the medical journal of the American Academy of Neurology. 'At the moment we have no way to predict who is at risk of...

2014-06-11 20:22:38

Data Presented at the 18th International Congress of Parkinson's Disease and Movement Disorders Demonstrate Highly Significant Improvement in Motor Function for Patients with Parkinson's Disease NATICK, Mass., June 11, 2014 /PRNewswire/ -- Patients with Parkinson's disease (PD) treated with the Boston Scientific Corporation (NYSE: BSX) Vercise(TM) Deep Brain Stimulation (DBS) System demonstrated a highly significant and consistent improvement in motor scores, according to the latest one-year...

2014-06-10 20:23:03

Data Presented at the International Congress of Parkinson's Disease and Movement Disorders Demonstrate Superior Therapeutic Window for the Treatment of Parkinson's Disease NATICK, Mass., June 10, 2014 /PRNewswire/ -- A new study has demonstrated a therapeutic advantage for a unique and innovative capability of the Boston Scientific (NYSE: BSX) Vercise(TM) Deep Brain Stimulation (DBS) System for the treatment of Parkinson's disease (PD). The CUSTOM-DBS clinical study demonstrated that shorter...

2014-06-10 08:32:25

MIAMI, June 10, 2014 /PRNewswire-USNewswire/ --The National Parkinson Foundation (NPF) released an important study stressing the importance of neurologist care at the 18(th) International Congress of Parkinson's Disease and Movement Disorders in Stockholm this week. The key finding is that expert neurologist care not only saves about 4,600 lives, but better access to this care could prevent the deaths of another nearly 7,000 people with Parkinson's disease (PD) each year in the U.S....

2014-06-10 08:31:23

EMERYVILLE, Calif., June 10, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today presented data on the rater and subject training process utilized in the Phase 2/3 EASED safety and efficacy study of ADS-5102 for the treatment of levodopa-induced dyskinesia (LID), a condition characterized by involuntary movements without purpose that can become severely disabling, rendering individuals with Parkinson's disease unable to perform routine daily tasks. In order to...

2014-06-09 16:25:26

EMERYVILLE, Calif., June 9, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) announced today that it has initiated a pivotal Phase 3 clinical study of ADS-5102 (amantadine HCl), a high-dose, controlled-release version of amantadine for the treatment of patients with Parkinson's disease who have developed levodopa-induced dyskinesia (LID). LID is a condition characterized by involuntary movements without purpose that can become severely disabling, rendering individuals...

2014-06-03 08:31:43

2014 Marks 10th Anniversary Celebration for Danville Concours/Weekend of Automotive Charity Events - Organization Raises More than $2mm to Support Parkinson's Research and Patient Care Since 2004 DANVILLE, Calif., June 3, 2014 /PRNewswire/ -- When this year's Danville d'Elegance (DDE) Foundation celebrates its upcoming 10th anniversary, September 20-21(st), 2014, with its annual weekend of automotive charity-related events, not only will it be boasting its stature as top fundraiser...

2014-05-29 16:26:44

EMERYVILLE, Calif., May 29, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced a poster presentation at the 18(th) International Congress of Parkinson's Disease and Movement Disorders from June 8 to 12, 2014, in Stockholm, Sweden. The poster (abstract #722) is titled "Rater training and data completeness in the study of ADS-5102 in levodopa-induced dyskinesia (EASED study)." The poster presentation will take place during the poster session "Parkinson's...

2014-05-29 12:29:26

MILAN, May 29, 2014 /PRNewswire/ -- Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related